Description
PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINA
FORMA FARMACÉUTICA: 5 AMPOLLETA
PRESENTACIÓN: 1 LATA
PRINCIPIO ACTIVO: PROTEINA
Prevención de eventos trombóticos en pacientes con enfermedad arterial periférica
PONDS S CRA 50G Terapia Reemplazo Hormonal PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINADOSIS: 50 G FORMA FARMACUTICA: 1 CREMA CORPORAL PRESENTACIN: 1 ENVASE
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
